Drug
Paroxetine Hydrochloride Controlled Release
Paroxetine Hydrochloride Controlled Release: highest development phase Phase 1, developed by Viatris. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Viatris
Trials
| Drug | Phase | Indication |
|---|---|---|
| Paroxetine Hydrochloride Controlled-Release Tablets 25 mg NCT00648427 | Phase 1 | Healthy |
Latest
No recent events.
Follow Paroxetine Hydrochloride Controlled Release on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.